Evidence map›Paper›PMID 20054827›Full record

ArticleJournal of cellular physiology2010

Regulation of the membrane mucin Muc4 in corneal epithelial cells by proteosomal degradation and TGF-beta.

Joseph Lomako, Wieslawa M Lomako, Coralie A Carothers Carraway, Kermit L Carraway

Abstract read
In one paragraph

Article in Journal of cellular physiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.1field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. The Role of the Ubiquitin System in Eye Diseases.Life (Basel, Switzerland) · 2025
    Review
  3. Reducing Sialylation Enhances Electrotaxis of Corneal Epithelial Cells.International journal of molecular sciences · 2023
    Article
  4. Human ocular mucins: The endowed guardians of sight.Advanced drug delivery reviews · 2022
    Review
  5. Review
  6. Review
  7. Article
  8. Corneal surface glycosylation is modulated by IL-1R andFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2017
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Joseph LomakoDepartment of Cell Biology and Anatomy, School of Medicine, University of Miami, Miami, Florida 33136, USA.
Wieslawa M Lomako
Coralie A Carothers Carraway
Kermit L Carraway
University of Miami · US

Funding

STRUCTURE/BIOSYNTHESIS OF TUMOR SIALOMUCIN COMPLEXR01CA052498 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI CARRAWAY, KERMIT L. · 1991 to 2009
$2.7M
OCULAR SURFACE PROTECTION BY SIALOMUCIN COMPLEXR01EY012343 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI CARRAWAY, KERMIT L. · 1999 to 2007
$1.5M
SIALOMUCIN COMPLEX AND UTERINE RECEPTIVITYR03HD035472 · NICHD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI CARRAWAY, KERMIT L. · 1997 to 1998
–
NCI NIH HHS R01 CA052498NCI NIH HHS R01 CA52498NEI NIH HHS R01 EY012343NEI NIH HHS R01 EY12343NICHD NIH HHS R03 HD035472
6 · The paper itself

Abstract

MUC4 is a heterodimeric membrane mucin, composed of a mucin subunit ASGP-1 (MUC4alpha) and a transmembrane subunit ASGP-2 (MUC4beta), which has been implicated in the protection of epithelial cell surfaces. In the rat stratified corneal epithelium Muc4 is found predominantly in the most superficial cell layers. Since previous studies in other tissues have shown that Muc4 is regulated by TGF-beta via a proteosomal degradation mechanism, we investigated the regulation of corneal Muc4 in stratified cultures of corneal epithelial cells. Application of proteosome or processing inhibitors led to increases in levels of Muc4, particularly in the basal and intermediate levels of the stratified cultures. These changes were accompanied by increases in Muc4 ubiquitination, chaperone association and incorporation into intracellular aggresomes. In contrast, treatment with TGF-beta resulted in reduced levels of Muc4, which were reversed by proteosome inhibition. The results support a model in which Muc4 precursor is synthesized in all layers of the corneal epithelium, but Muc4 is degraded in basal and intermediate layers by a proteosomal mechanism at least partly dependent on TGF-beta inhibition of Muc4 processing.

Indexed as

Protein Processing, Post-TranslationalAlkaloidsAnimalsCalnexinCalreticulinCell MembraneCells, CulturedCysteine Proteinase InhibitorsEndoplasmic ReticulumEpithelial CellsEpithelium, CornealMannosidasesMucin-4OligopeptidesProteasome Endopeptidase ComplexProteasome InhibitorsAlkaloidsbenzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinalCalnexinCalreticulinCysteine Proteinase InhibitorskifunensineMannosidasesMuc4 protein, ratMucin-4OligopeptidesProteasome Endopeptidase ComplexProteasome InhibitorsTransforming Growth Factor beta

Identifiers

PMID20054827
PMCPMC2873043
OpenAlexW2155471567

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.